Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase (HSV-tk) suicide gene in cancer gene therapy

被引：0
|
作者：
Lanuti, M
Gao, GP
Force, SD
Chang, MY
El Kouri, C
Amin, KM
Hughes, JV
Wilson, JM
Kaiser, LR
Albelda, SM
机构：
[1] Univ Penn, Med Ctr, Dept Surg, Thorac Oncol Res Lab, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Med, Div Pulm Crit Care, Philadelphia, PA 19104 USA
[3] Univ Penn, Med Ctr, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
[4] Univ Penn, Med Ctr, Wistar Inst, Philadelphia, PA 19104 USA
来源：
CANCER GENE THERAPY | 1998年 / 5卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
O26
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [21] Adenovirus-mediated herpes simplex thymidine kinase gene therapy for brain tumors
    Sandmair, AM
    Vapalahti, M
    Ylä-Herttuala, S
    CANCER GENE THERAPY, 2000, 465 : 163 - 170
  • [22] Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase
    Oh, Jin Young
    Park, Mi Young
    Kim, Dal Rae
    Lee, Jung Hee
    Shim, Seon-Hui
    Chung, Jin-Haeng
    Yoon, Ho-Il
    Lee, Jae Ho
    Sung, Myung-Whun
    Kim, Yeon-Soo
    Lee, Choon-Taek
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (03) : 369 - 376
  • [23] SITES OF INTEGRATION OF HERPES-SIMPLEX VIRUS (HSV) THYMIDINE KINASE (TK) GENE IN TRANSFORMED HUMAN CELLS
    DONNER, L
    KIT, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 171 - 171
  • [24] Treatment of human papillomavirus (HPV) type 16 virus-infected cells using the herpes simplex virus thymidine kinase (HSV-TK) gene
    Sethi, N
    Palefsky, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (03) : A33 - A33
  • [25] Combination Treatment of Adenovirus Mediated HSV-Thymidine Kinase Suicide Gene Therapy and Docetaxel in Bladder Cancer
    Yamashita, Hideyuki
    Jian, Weiguo
    Gillbert, April
    Lerner, Seth P.
    MOLECULAR THERAPY, 2006, 13 : S365 - S365
  • [26] Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model
    Fogar, P
    Greco, E
    Basso, D
    Habeler, W
    Navaglia, F
    Zambon, CF
    Tormen, D
    Gallo, N
    Cecchetto, A
    Plebani, M
    Pedrazzoli, S
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (09): : 721 - 730
  • [27] THE ROLE OF IMMUNOSUPPRESSION IN THE EFFICACY OF CANCER GENE-THERAPY USING ADENOVIRUS TRANSFER OF THE HERPES-SIMPLEX THYMIDINE KINASE GENE
    ELSHAMI, AA
    KUCHARCZUK, JC
    STERMAN, DH
    SMYTHE, WR
    HWANG, HC
    AMIN, KM
    LITZKY, LA
    ALBELDA, SM
    KAISER, LR
    ANNALS OF SURGERY, 1995, 222 (03) : 298 - 310
  • [28] A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients
    Alvarez, RD
    Curiel, DT
    HUMAN GENE THERAPY, 1997, 8 (05) : 597 - 613
  • [29] Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy
    Nasu, Yasutomo
    Saika, Takashi
    Ebara, Shin
    Kusaka, Nobuyuki
    Kaku, Haruki
    Abarzua, Fernando
    Manabe, Daisuke
    Thompson, Timothy C.
    Kumon, Hiromi
    MOLECULAR THERAPY, 2007, 15 (04) : 834 - 840
  • [30] Herpes simplex virus thymidine kinase (HSV-TK) murine vector producer cell (VPC) xenografts in women with recurrent ovarian cancer
    Link, CJ
    Moorman, DW
    Levy, J
    Tennant, L
    Edleman, M
    McDermott, J
    Galili, U
    Seregina, T
    CANCER GENE THERAPY, 1998, 5 (06) : S17 - S17
12345